Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Takemoto

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|February 3, 2018
Phenotypic Variation in 46,XX Disorders of Sex Development due to the NR5A1 p.R92W Variant: A Sibling Case Report and Literature ReviewKei Takasawa, Maki Igarashi, Makoto Ono, et al.
The Oncologist|August 12, 2025
Characterization of a novel comprehensive genomic profiling test with better detection of heterozygous deletions and RNA-based gene fusion analysisRyouta Kakuta, Akira Takemoto, Kousuke Tanimoto, et al.
Iscience|February 7, 2022
Immune subtypes and neoantigen-related immune evasion in advanced colorectal cancerToshitaka Sugawara, Fuyuki Miya, Toshiaki Ishikawa, et al.
Immunotherapy|May 5, 2020
Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case reportYuki Iijima, Rie Sakakibara, Masahiro Ishizuka, et al.
Cancer Medicine|September 15, 2023
The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancerTakayuki Honda, Katsutoshi Seto, Satoshi Endo, et al.
JTCVS Open|September 19, 2024
Immunohistochemistry of p53 surrogates <i>TP53</i> mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinomaYasuyuki Kurihara, Takayuki Honda, Akira Takemoto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2024
Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell CarcinomaHajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 2, 2019
Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinomaFukiko Kawai-Kitahata, Yasuhiro Asahina, Shun Kaneko, et al.
Endocrine Pathology|August 27, 2022
PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and ParagangliomaMinami Miyauchi, Takumi Akashi, Asuka Furukawa, et al.
World Journal of Surgical Oncology|August 10, 2018
Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 studyHiroshi Urakawa, Tsukasa Yonemoto, Seiichi Matsumoto, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|February 3, 2018
Phenotypic Variation in 46,XX Disorders of Sex Development due to the NR5A1 p.R92W Variant: A Sibling Case Report and Literature ReviewKei Takasawa, Maki Igarashi, Makoto Ono, et al.
The Oncologist|August 12, 2025
Characterization of a novel comprehensive genomic profiling test with better detection of heterozygous deletions and RNA-based gene fusion analysisRyouta Kakuta, Akira Takemoto, Kousuke Tanimoto, et al.
Iscience|February 7, 2022
Immune subtypes and neoantigen-related immune evasion in advanced colorectal cancerToshitaka Sugawara, Fuyuki Miya, Toshiaki Ishikawa, et al.
Immunotherapy|May 5, 2020
Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case reportYuki Iijima, Rie Sakakibara, Masahiro Ishizuka, et al.
Cancer Medicine|September 15, 2023
The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancerTakayuki Honda, Katsutoshi Seto, Satoshi Endo, et al.
JTCVS Open|September 19, 2024
Immunohistochemistry of p53 surrogates <i>TP53</i> mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinomaYasuyuki Kurihara, Takayuki Honda, Akira Takemoto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2024
Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell CarcinomaHajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 2, 2019
Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinomaFukiko Kawai-Kitahata, Yasuhiro Asahina, Shun Kaneko, et al.
Endocrine Pathology|August 27, 2022
PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and ParagangliomaMinami Miyauchi, Takumi Akashi, Asuka Furukawa, et al.
World Journal of Surgical Oncology|August 10, 2018
Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 studyHiroshi Urakawa, Tsukasa Yonemoto, Seiichi Matsumoto, et al.
Pageof 3